FORMIGARO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.524
EU - Europa 468
AS - Asia 300
OC - Oceania 3
Totale 2.295
Nazione #
US - Stati Uniti d'America 1.524
CN - Cina 176
IT - Italia 108
DE - Germania 106
TR - Turchia 85
GB - Regno Unito 57
UA - Ucraina 55
SE - Svezia 49
SG - Singapore 28
BE - Belgio 27
FI - Finlandia 16
RU - Federazione Russa 12
FR - Francia 11
CZ - Repubblica Ceca 9
PL - Polonia 8
VN - Vietnam 5
IE - Irlanda 4
AU - Australia 3
NL - Olanda 3
ID - Indonesia 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
MK - Macedonia 1
UZ - Uzbekistan 1
Totale 2.295
Città #
Woodbridge 233
Fairfield 211
Ann Arbor 172
Chandler 118
Houston 111
Ashburn 94
Jacksonville 79
Seattle 79
Cambridge 66
Wilmington 65
Beijing 62
Ferrara 52
Nanjing 38
Izmir 34
New York 34
Brussels 27
Shanghai 22
Singapore 22
Milan 20
Princeton 20
Addison 16
San Diego 16
Boardman 15
Bremen 13
Shenyang 11
Brno 9
Los Angeles 8
Nanchang 8
Warsaw 8
Falls Church 6
Tianjin 6
Changsha 5
Dong Ket 5
Jinan 5
Augusta 4
Des Moines 4
Dublin 4
Hebei 4
London 4
Ningbo 4
Illasi 3
Jiaxing 3
Norwalk 3
Hangzhou 2
Jakarta 2
Kunming 2
Mountain View 2
Orange 2
Redwood City 2
Acton 1
Anzola Dell'emilia 1
Ardabil 1
Berlin 1
Central 1
Colico 1
Edinburgh 1
Lanzhou 1
Leawood 1
Melbourne 1
Perth 1
Pescara 1
Redmond 1
Rome 1
Simi Valley 1
Stockholm 1
Tallinn 1
Velp 1
Venezia 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 1.757
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 155
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 130
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 127
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 122
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 120
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 116
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 112
Delirium in acute promyelocytic leukemia patients: two case reports. 111
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 107
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 101
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 98
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 89
null 88
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 87
null 64
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 25
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 17
Totale 2.328
Categoria #
all - tutte 10.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 23 75 38 56 56 42 53 40 20 13
2020/2021389 18 32 19 34 14 37 18 35 8 71 73 30
2021/2022267 32 15 8 8 13 15 30 10 9 24 33 70
2022/2023274 28 27 17 36 46 36 24 18 24 0 13 5
2023/2024133 11 13 5 3 3 43 8 8 2 2 1 34
2024/202525 14 11 0 0 0 0 0 0 0 0 0 0
Totale 2.328